Literature DB >> 10739430

Proton magnetic resonance spectroscopy of the medial prefrontal cortex in patients with deficit schizophrenia: preliminary report.

P Delamillieure1, J Fernandez, J M Constans, P Brazo, K Benali, P Abadie, T Vasse, F Thibaut, P Courthéoux, M Petit, S Dollfus.   

Abstract

OBJECTIVE: Proton magnetic resonance spectroscopy (1H-MRS) was used to study medial prefrontal metabolic impairments in schizophrenic patients with the deficit syndrome.
METHOD: The subjects were 22 schizophrenic patients categorized as deficit (N=5) or nondeficit (N=17) and 21 healthy subjects. (1)H-MRS was performed for the right and the left medial prefrontal cortex.
RESULTS: The patients with the deficit syndrome had significantly lower ratios of N-acetylaspartate to creatine plus phosphocreatine than did the healthy subjects or nondeficit patients.
CONCLUSIONS: As N-acetylaspartate levels could reflect neuronal density and/or viability, this finding suggests a neuronal loss in the medial prefrontal cortex of deficit patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10739430     DOI: 10.1176/appi.ajp.157.4.641

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  14 in total

Review 1.  Neurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysis.

Authors:  Nina Vanessa Kraguljac; Meredith Reid; David White; Rebecca Jones; Jan den Hollander; Deborah Lowman; Adrienne Carol Lahti
Journal:  Psychiatry Res       Date:  2012-09-13       Impact factor: 3.222

2.  Progress in the study of negative symptoms.

Authors:  Brian Kirkpatrick
Journal:  Schizophr Bull       Date:  2014-03       Impact factor: 9.306

3.  Executive functioning and psychopathological profile in relatives of individuals with deficit v. non-deficit schizophrenia: a pilot study.

Authors:  S Scala; A Lasalvia; L J Seidman; D Cristofalo; C Bonetto; M Ruggeri
Journal:  Epidemiol Psychiatr Sci       Date:  2013-04-02       Impact factor: 6.892

Review 4.  [Magnetic resonance spectroscopy in schizophrenia. Possibilities and limitations].

Authors:  T Wobrock; H Scherk; P Falkai
Journal:  Radiologe       Date:  2005-02       Impact factor: 0.635

Review 5.  T2 relaxation effects on apparent N-acetylaspartate concentration in proton magnetic resonance studies of schizophrenia.

Authors:  Bethany K Bracken; Elizabeth D Rouse; Perry F Renshaw; David P Olson
Journal:  Psychiatry Res       Date:  2013-06-12       Impact factor: 3.222

6.  Deficit schizophrenia: an update.

Authors:  Brian Kirkpatrick; Silvana Galderisi
Journal:  World Psychiatry       Date:  2008-10       Impact factor: 49.548

7.  Clinical and cognitive correlates of the proton magnetic resonance spectroscopy measures in chronic schizophrenia.

Authors:  Agata Szulc; Beata Galińska-Skok; Eugeniusz Tarasów; Beata Konarzewska; Napoleon Waszkiewicz; Rafał Hykiel; Jerzy Walecki
Journal:  Med Sci Monit       Date:  2012-06

8.  White matter alterations in deficit schizophrenia.

Authors:  Laura M Rowland; Elena A Spieker; Alan Francis; Peter B Barker; William T Carpenter; Robert W Buchanan
Journal:  Neuropsychopharmacology       Date:  2008-12-03       Impact factor: 7.853

9.  Deficit schizophrenia: Concept and validity.

Authors:  Sandeep Grover; Parmanand Kulhara
Journal:  Indian J Psychiatry       Date:  2008-01       Impact factor: 1.759

10.  White Matter Neurometabolic Signatures Support the Deficit and Nondeficit Distinction in Antipsychotic-Naïve First-Episode Psychosis Patients.

Authors:  James Edward Bryant; Adrienne Carol Lahti; Frederic Briend; Nina Vanessa Kraguljac
Journal:  Schizophr Bull       Date:  2021-07-08       Impact factor: 7.348

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.